Dr. Samuel Inverso is an experienced interdisciplinary leader with a demonstrated history of success in technology and life sciences. Sam co-founded ReadCoor, which spun out of the Wyss Institute at Harvard University, and after multiple funding rounds was acquired by 10x Genomics for $350 million. He has formed and run cross-functional teams of molecular biologists, software engineers, and bioinformaticians in large scale multi-year multi-million-dollar projects. He has driven business development, revenue generation, and lead partnerships from pharma, universities, and the federal government. Sam excels and enjoys building and communicating strategic frameworks that bridge science and business perspectives.